325 Capital LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), 325 Capital LLC reported 12 stock positions worth $419.5 million. Its top holding was Astrana Health (ASTH) at 17.9% of the portfolio, followed by Magnite (MGNI, 15.4%) and American Public Education (APEI, 15.2%). Compared with Q1 2026, it added to 5 and reduced 1. The biggest buy was Magnite (MGNI, shares +70%) and the biggest sale Astrana Health (ASTH, shares −12%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001873893
- Portfolio Value
- $419.5M (Q2 2026)
- SEC Filing
- 0001214659-26-010357 ↗ filed Aug 14, 2026
Holdings Value
Holdings 12 stocks · $419.5M
| ASTH Astrana Health Inc. | 17.85% | 1,613,843 | $74.9M | Reduce -12.3% |
| MGNI Magnite Inc. | 15.44% | 3,412,694 | $64.8M | Add +70.2% |
| APEI American Public Education | 15.15% | 1,183,732 | $63.6M | No change |
| BLBD Blue Bird Corp. | 13.39% | 711,390 | $56.2M | Add +4.6% |
| SPIR Spire Global Inc. | 13.15% | 2,966,932 | $55.2M | Add +58.2% |
| MPAA Motorcar Parts of America Inc. | 7.37% | 2,018,795 | $30.9M | No change |
| DBD Diebold Nixdorf Inc. | 4.91% | 242,084 | $20.6M | No change |
| AIOT Powerfleet Inc. | 4.82% | 5,283,000 | $20.2M | Add +37.7% |
| LFCR Lifecore Biomedical Inc. | 3.62% | 2,895,881 | $15.2M | Add +33.9% |
| BTMD Biote Corp. Class A | 2.05% | 4,548,127 | $8.6M | No change |
| TACT Transact Technologies Inc. | 1.41% | 1,011,789 | $5.9M | No change |
| MSAI Multisensor AI Holdings Inc. | 0.82% | 662,244 | $3.5M | No change |
Portfolio Sells Q1 2026 → Q2 2026
| ASTH Astrana Health Inc. | Reduce -12.3% | 17.85% | +1.43 |
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $419.5M | ASTH, MGNI, APEI, BLBD, SPIR |
| Q1 2026 | 12 | $274.5M | APEI, ASTH, BLBD, MGNI, SPIR |
| Q4 2025 | 13 | $285.4M | APEI, ASTH, MGNI, BLBD, MPAA |
| Q3 2025 | 12 | $329.1M | ATRO, APEI, BLBD, ASTH, MPAA |
| Q2 2025 | 11 | $253.3M | APEI, ATRO, BLBD, MPAA, SPIR |
| Q1 2025 | 11 | $241.4M | APEI, ATRO, ASTH, BLBD, AIOT |
| Q4 2024 | 12 | $258.7M | APEI, BLBD, BTMD, ASTH, ATRO |
| Q3 2024 | 11 | $236.2M | ASTH, BLBD, ATRO, APEI, BTMD |
| Q2 2024 | 13 | $238.1M | BLBD, ATRO, BTMD, ASTH, APEI |
| Q1 2024 | 12 | $216.6M | BLBD, ATRO, SGOV, ASTH, BTMD |